Frankfurt - Delayed Quote EUR

InnoCan Pharma Corporation (IP4.F)

0.1855 +0.0010 (+0.54%)
As of 9:59 AM GMT+2. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for IP4.F

Recent News: IP4.F

View More
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain

Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
CNW Group 3 days ago
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M
CNW Group 24 days ago
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.

Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.
CNW Group last month
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million
CNW Group last month
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study

Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study
CNW Group last month
Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits

Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits
CNW Group last month
Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024

Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024
CNW Group 2 months ago
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights

Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights
CNW Group 2 months ago
Innocan Pharma to provide a corporate update via Zoom livestream on February 12, 2024, at 4:00pm EST

Innocan Pharma to provide a corporate update via Zoom livestream on February 12, 2024, at 4:00pm EST
CNW Group 2 months ago
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration

Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration
CNW Group 4 months ago
Innocan Pharma Reports Q3 2023 Results Including US$3.334M Increase in Revenues Compared to Q3, 2022

Innocan Pharma Reports Q3 2023 Results Including US$3.334M Increase in Revenues Compared to Q3, 2022
CNW Group 4 months ago
Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications from a prolong use in animals

Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications from a prolong use in animals
CNW Group 5 months ago
View More

Related Tickers

EVT.F Evotec SE
9.17
-1.93%
 
ETON Eton Pharmaceuticals, Inc.
3.1200
-2.80%
 
PCRX Pacira BioSciences, Inc.
25.50
-1.54%
 
CYTH Cyclo Therapeutics, Inc.
1.2900
0.00%
 
HCM HUTCHMED (China) Limited
18.99
+3.15%
 
EVT.DE Evotec SE
9.47
+3.38%
 
CRDL Cardiol Therapeutics Inc.
1.8400
+4.55%
 
PTPI Petros Pharmaceuticals, Inc.
0.6399
+0.87%
 
OPTN OptiNose, Inc.
0.9050
-2.19%
 
RDHL RedHill Biopharma Ltd.
0.4162
-0.88%